Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and Granulocytic Leukemia, Chronic

lamivudine has been researched along with Granulocytic Leukemia, Chronic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandwein, J; Gupta, V; Kamel-Reid, S; Lipton, JH; Messner, HA; Minden, MD1
Chiba, T; Fukai, K; Imamura, T; Imazeki, F; Kanda, T; Kojima, H; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O1
Cetin, M; Demir, H; Kasem, M; Kuşkonmaz, B; Tavil, B; Uçkan, D1
Sobhonslidsuk, A; Ungkanont, A1
Asaka, M; Chiba, K; Hashino, S; Hige, S; Izumiyama, K; Kondo, T; Nozawa, A; Suzuki, S; Yonezumi, M1

Other Studies

5 other study(ies) available for lamivudine and Granulocytic Leukemia, Chronic

ArticleYear
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
    Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Hepatitis B; Humans; Imatinib Mesylate; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Salvage Therapy; Vincristine

2003
Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:6

    Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; DNA Replication; Female; Graft vs Host Disease; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Middle Aged; Mutation

2005
Hepatitis B immunoglobulin in combination with lamivudine for prevention of hepatitis B virus reactivation in children undergoing bone marrow transplantation.
    Pediatric transplantation, 2006, Volume: 10, Issue:8

    Topics: beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunologic Factors; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Transplantation, Homologous; Virus Activation

2006
A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor.
    World journal of gastroenterology, 2007, Feb-21, Volume: 13, Issue:7

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Tissue Donors; Viral Load

2007
Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 2002, Volume: 29, Issue:4

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Humans; Immunosuppression Therapy; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recurrence; Time Factors; Transplantation, Homologous

2002